Stay updated on BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities

Sign up to get notified when there's something new on the BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities page.
Latest website image capture
Clouds background image

Latest updates to the BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The completed Phase 1 BGB-A317 study record is now displayed, including its eligibility criteria, study design, outcome measures, results-related information, and study documents.
    Difference
    68%
    Check dated 2026-11-09T03:50:52.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0 while the study record remains inaccessible behind a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-11-02T02:47:47.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces updates about the agency’s website transition and notes that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T04:15:07.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T06:46:08.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision indicator changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T02:46:27.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page, complete with a DOCTYPE and a 403 header, and a Home link, signaling the study record is inaccessible; the footer shows a revision version and previously visible documents/details are no longer displayed on the page.
    Difference
    19%
    Check dated 2026-09-21T00:44:34.000Z thumbnail image

Stay in the know with updates to BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities

Enter your email address, and we'll notify you when there's something new on the BGB-A317 Clinical Trial: Safety, PK, Antitumor Activities page.